Company intelligence / Profile preview

Aileens Pharma

Milan, Lombardy, Italyaileenspharma.com ↗

Ownership: Private
Employees: ~6
Development stage: Preclinical

Overview

Aileens Pharma develops topical, non-steroidal and non-pharmacological medical devices for inflammatory skin diseases with a primary focus on pediatric atopic dermatitis. Their lead functional ingredient, HAc40, modulates inflammation by acting on the skin microbiota and neutralizing toxins from pathogens. Products are approved in the EU for use from birth onward. The company aims to provide safer alternatives to steroids and immunomodulators—especially important given concerns about side effects in children. Backed by Italian investors including Panakes Partners SGR and CDP Ventures.

Therapeutic areas: Dermatology
Modalities: Topical non-pharmacological treatmentsmedical devices
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

LimpiAD

Pre-clinical

Indications: Atopic dermatitis

Partnerships

No major pharma partnerships disclosed; supported by Italian venture capital funds Panakes Partners SGR and CDP Ventures

Beyond the preview

Go deeper on Aileens Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aileens Pharma.

Explore the full profile